Big Sky Health, Inc.

Big Sky Health, Inc. develops the Zero app, an innovative intermittent fasting tracker that empowers users to enhance their health and weight loss efforts through targeted lifestyle modifications. Founded in 2016, Big Sky Health, Inc. is based in San Francisco, US, and specializes in health technology focused on intermittent fasting.

The company has attracted attention within the health tech space and raised USD 8. 00 mn in Series A funding on May 19, 2020, led by Greycroft Partners, with participation from Trinity Ventures and True Ventures. The company's CEO is Mike Maser, and it has completed a total of 3 deals since its inception. Zero Longevity Science specializes in an innovative intermittent fasting tracker app designed to support users in their weight loss and health improvement journeys.

The app facilitates the creation of sustainable health habits through a framework that incorporates intermittent fasting alongside other lifestyle modifications such as mindful eating, physical activity, and restorative practices. Key features include a fasting timer, personalized health tracking, and integration with other health applications, which collectively enhance user engagement and motivation. The core functionality aims to assist individuals in managing their dietary behaviors, achieving weight loss, and improving overall health metrics. The app is available in various geographical markets, with a user base that spans across North America, Europe, and Asia, targeting individuals motivated to adopt healthier lifestyles and improve their longevity.

Zero Longevity Science generates revenue primarily through a subscription model for its app, which offers users access to premium features and personalized guidance. Users can select from different pricing plans that provide varying levels of service and support, including features that cater to both beginners and experienced practitioners of intermittent fasting. The business operates on a direct-to-consumer basis, allowing individuals to purchase subscriptions independently, as well as potential partnerships that may enhance customer acquisition. Transactions are structured to foster ongoing relationships with users, ensuring continued engagement and support as they progress toward their health goals.

The flagship offering, the Zero app, is central to these transactions and plays a crucial role in the company's revenue generation strategy. In May 2020, Big Sky Health, Inc. raised USD 8 million in Series A funding led by Greycroft Partners, which will support its strategy for future growth. The company plans to enhance its existing app features and introduce new functionalities aimed at improving user experience.

Additionally, it is exploring expansion into new markets across Asia and Europe by the end of 2023, allowing it to reach a broader audience seeking health improvement tools.